MARKET

SER

SER

Serina Therapeutics
AMEX
2.120
0.000
0.00%
After Hours: 2.240 +0.12 +5.66% 19:39 04/02 EDT
OPEN
2.110
PREV CLOSE
2.120
HIGH
2.160
LOW
1.900
VOLUME
409.59K
TURNOVER
--
52 WEEK HIGH
7.92
52 WEEK LOW
1.220
MARKET CAP
26.11M
P/E (TTM)
-1.1262
1D
5D
1M
3M
1Y
5Y
1D
Serina Therapeutics wins NYSE approval; 2027 listing compliance deadline set
Seeking Alpha · 1d ago
Serina Therapeutics announces NYSE acceptance of plan to regain compliance
TipRanks · 1d ago
Weekly Report: what happened at SER last week (0323-0327)?
Weekly Report · 4d ago
Analysts’ Top Healthcare Picks: Serina Therapeutics (SER), Pharma Mar SA (PHMMF)
TipRanks · 03/27 13:40
Serina Therapeutics GAAP EPS of -$1.91, revenue of $0.13M
Seeking Alpha · 03/26 08:03
Serina Therapeutics Q4 EPS $(0.31) Beats $(0.46) Estimate
Benzinga · 03/25 20:37
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 03/25 17:05
Top Executive Makes Notable Move With Serina Therapeutics Stock
TipRanks · 03/25 02:05
More
About SER
Serina Therapeutics Inc. is a clinical-stage biotechnology company developing a pipeline of wholly owned drug product candidates to treat neurological diseases and other indications. The Company's POZ Platform provides the potential to improve the integrated efficacy and safety profile of multiple modalities including small molecules, RNA-based therapeutics and antibody-based drug conjugates (ADCs). Its proprietary POZ technology is based on a synthetic, water soluble, low viscosity polymer called poly(2-oxazoline). Its POZ technology is engineered to provide greater control in drug loading and more precision in the rate of release of attached drugs delivered via subcutaneous injection. SER-252 is the Company’s lead candidate for advanced Parkinson’s disease. SER-252 is an investigational apomorphine therapy developed with its POZ platform and designed to provide continuous dopaminergic stimulation.

Webull offers Serina Therapeutics Inc stock information, including AMEX: SER real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SER stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SER stock methods without spending real money on the virtual paper trading platform.